The CRISPR-Cas9 system provides the ability to edit, repress, activate, or mark any gene (or DNA element) by pairing of a programmable single guide RNA (sgRNA) with a complementary sequence on the DNA target. Here we present a new method for small-molecule control of CRISPR-Cas9 function through insertion of RNA aptamers into the sgRNA. We show that CRISPR-Cas9-based gene repression (CRISPRi) can be either activated or deactivated in a dose-dependent fashion over a >10-fold dynamic range in response to two different small-molecule ligands. Since our system acts directly on each target-specific sgRNA, it enables new applications that require differential and opposing temporal control of multiple genes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509140PMC
http://dx.doi.org/10.1038/s41467-019-09985-2DOI Listing

Publication Analysis

Top Keywords

controlling crispr-cas9
4
crispr-cas9 ligand-activated
4
ligand-activated ligand-deactivated
4
ligand-deactivated sgrnas
4
sgrnas crispr-cas9
4
crispr-cas9 system
4
system ability
4
ability edit
4
edit repress
4
repress activate
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!